Here are relevant reports on : crispr-diagnostics-market
-
Autoimmunity Diagnostics Market by Product (Consumables, Instruments), Test Type (Routine, Autoantibody, Inflammatory, Urinalysis Tests), Disease (RA, SLE, MS, IBD), End User (Clinical Laboratories, Hospitals & Clinics) - Global Forecast to 2031
The global autoimmunity diagnostics market, valued at US$5.26 billion in 2024, stood at US$5.57 billion in 2025 and is projected to advance at a resilient CAGR of 8.3% from 2025 to 2031, culminating in a forecasted valuation of US$8.98 billion by the end of the period. The autoimmunity diagnostics market is consistently growing, fueled by several key factors. These include the rising prevalence of autoimmune disease, growing awareness about early and accurate diagnosis, increasing research activities, and rapid advancements in diagnostic technologies.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Laboratory Centrifuges Market by Product [Equipment (Microcentrifuge, Ultracentrifuge), Accessories (Tube, Plate)], Platform (Benchtop), Rotor Design (Swinging-bucket), Intended Use (Clinical), Application (Diagnostics), End User (Hospitals) - Global Forecast to 2030
The global laboratory centrifuges market, valued at US$1.53 billion in 2024, stood at US$1.58 billion in 2025 and is projected to advance at a resilient CAGR of 2.8% from 2024 to 2030, culminating in a forecasted valuation of US$1.86 billion by the end of the period. This growth is driven by increased R&D investments and research grants, technological advancements and innovative rotor designs, a rise in infectious diseases that boosts sample testing and cell-based research, and expanding applications of these centrifuges.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Oligonucleotide Synthesis Market by Product ((Drugs (ASO, siRNA), Synthesized Oligos (Product (Primers, Probes)), Type ((Custom, Predesigned), Reagents, Equipment), Application (Therapeutic (Rare Diseases), Research, Diagnostics) - Global Forecast to 2030
The global oligonucleotide synthesis market, valued at US$8.9 billion in 2024, stood at US$10.5 billion in 2025 and is projected to advance at a resilient CAGR of 18.6% from 2025 to 2030, culminating in a forecasted valuation of US$24.7 billion by the end of the period. The oligonucleotide synthesis market is experiencing significant growth, driven by the increasing applications of synthesized oligonucleotides in therapeutics & diagnostics. This growth is supported by technological advancements and rising investments in life sciences research and synthetic biology.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
In Situ Hybridization Market by Offering (Consumables, Instruments, Software), Technology (FISH (DNA FISH, RNA, PNA), CISH), Application (Cancer Diagnostics, Research, Discovery), End User (Hospitals, Pharma & Biotech, Academia) - Global Forecast to 2030
The global in situ hybridization market, valued at US$1.55 billion in 2024, stood at US$1.64 billion in 2025 and is projected to advance at a resilient CAGR of 7.4% from 2025 to 2030, culminating in a forecasted valuation of US$2.35 billion by the end of the period. The growth in the field of in situ hybridization (ISH) is significantly driven by ongoing advancements in technology, including high-sensitivity probes, automated systems, and multiplexing solutions.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Telehealth and Telemedicine Market by Function (Teleconsultation, RPM, Diagnostics & Treatment, Analytics, Administrative), Application (TelelCU, Teleradiology, Telecardiology, Diabetes), End User (Hospital, ASC, Payer), & Region - Global Forecast to 2030
The global telehealth and telemedicine market, valued at US$83.62B in 2023, is forecasted to grow at a 11.5% CAGR, reaching US$94.14B by 2024 and US$180.86B by 2030. The telehealth and telemedicine market is experiencing significant growth primarily driven by the growing geriatric and medically underserved (especially rural) populations, the growing prevalence of chronic conditions, the benefits of telehealth & telemedicine given the current shortage of physicians and care personnel, and advancements in telecommunication technologies, and expansion of remote patient monitoring (RPM) systems.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Allergy Diagnostics Market by Product & Service (Consumables, Instruments [Immunoassay Analyzers, Luminometers]), Test Type (In Vivo Tests, In Vitro Tests), Allergen (Food Allergens), End User (Hospital-Based Laboratories) - Global Forecast to 2031
The global Allergy Diagnostics market, valued at USD 6.23 billion in 2025, stood at USD 6.80 billion in 2026 and is projected to advance at a resilient CAGR of 9.6% from 2026 to 2031, culminating in a forecasted valuation of USD 10.77 billion by the end of the period. Allergy diagnostics fit squarely into this paradigm by enabling early detection of sensitization before severe clinical manifestations occur.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Western Blotting Market by Product, (Consumables (Antibody), Instrument (Electrophoresis, Blotting System, Imager (Fluorescent))), Application (Biomedical, Clinical Diagnostics), End User (Research Institute, Hospital, Biopharma) & Region - Global Forecast to 2026
The global western blotting market growth is primed to transition from $1.0 billion in 2021 to $1.4 billion by 2026, showcasing a strong CAGR of 6.7%. Technological advancements, increasing government funding in the field of biomedical research, growing demand for personalized medicine, and the rising prevalence of HIV are the key factors driving the market growth.
- Published: November 2021
- Price: $ 4950
- TOC Available:
-
ASEAN Point of Care Diagnostics Market by Product (Infectious Disease (TB, Hepatitis, STDs, HAIs), Glucose, Cardiometabolic, Pregnancy, Coagulation), Technology (Lateral Flow Assays, Biochemistry, MDx), End User (Home Care, Hospitals) - Forecast to 2030
Global ASEAN point of care diagnostics market valued at $1.05B in 2024, reached $1.08B in 2025, and is projected to grow at a robust 4.7% CAGR, hitting $1.36B by 2030. The increasing incidence of chronic conditions, especially diabetes, generates the demand for regular monitoring and early detection, boosting the need for rapid & accurate POC testing solutions
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Bus & Public Transport Fleet Management Market by Operation (Operations Management, Vehicle Maintenance & Diagnostics, Performance Management, Compliance Management), By Fleet Type (Urban Transit, Suburban & Inter-city, Shuttle) - Global Forecast to 2030
The Bus & Public Transport Fleet Management System Market is projected to reach USD 15.71 billion by 2030, from USD 8.65 billion in 2025, at a CAGR of 12.7% from 2025 to 2030.The key players include Geotab (Canada), Samsara (US), Verizon Connect (US), Webfleet (Netherlands), MiX Telematics (South Africa), Teletrac Navman (US), Fleet Complete (Canada), Zonar Systems (US), ChargePoint (US), Virta (Finland), Driivz (Israel), Siemens (Germany), ABB (Switzerland), Shell (UK), and LocoNav (India).
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Nucleic Acid Isolation and Purification Market by Product (Kits, Reagents, Instruments), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA), Application (Diagnostics, Personalized Medicine), & End User (CROs) - Forecast to 2030
The Asia Pacific nucleic acid isolation and purification market, valued at USD1.49 billion in 2024, stood at USD1.61 billion in 2025 and is projected to advance at a resilient CAGR of 10.5% from 2025 to 2030, culminating in a forecasted valuation of USD2.65 billion by the end of the period. The Asia Pacific market for nucleic acid isolation and purification is expanding due to the increasing number of molecular tests and the scale-up of PCR and NGS across the region.
- Published: June 2026
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
